Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer. - Perez, Edith A.; de Haas, Sanne Lysbet; Eiermann, Wolfgang; Barrios, Carlos H.; Toi, Masakazu; Im, Young-Hyuck; Conte, Pier Franco; Martin, Miguel; Pienkowski, Tadeusz; Pivot, Xavier B.; Burris III, Howard A.; Stanzel, Sven; et al. (BMC Cancer, 2019)